Physicochemical characterization and in vitro dissolution behaviour of celecoxib-β-cyclodextrin inclusion complexes

Acta Pharmaceutica

Volumn 57, Issue 1, 2007, Pages 47-60

  Sinha, Vivek Ranjan ^a   Anitha, R ^a   Ghosh, Soma ^b   Amita, ^a   Kumria, Rachana ^a   Bhinge, Jayant Rajaram ^a   Kumar, Manoj ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Celecoxib; Dissolution profile; Inclusion complex; cyclodextrin

Indexed keywords

BETA CYCLODEXTRIN; CELECOXIB;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLOOXYGENASE 2 INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; PYRAZOLES; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; SULFONAMIDES; X-RAY DIFFRACTION;

EID: 33847620316     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0004-x     Document Type: Article

References (27)

1. V. Stella and R. Rajewski, Cyclodextrins: Their future in drug formulation and delivery, Pharm. Res. 14 (1997) 556-567.
2. A. Latrofa, G. Trapani, M. Franco, M. Serra, M. Muggironi, F. P. Fanizzi, A. Cutrignelli and G. Liso, Complexation of phenytoin with some hydrophilic cyclodextrins effect on aqueous solubility, dissolution rate and anticonvulsant activity in mice, Eur. J. Pharm. Biopharm. 52 (2001) 65-73.
3. C. W. Park, S. J. Kim, S. J. Park, J. H. Kim, J. K. Kim, G. B. Park, J. O. Kim and Y. I. Ha, Inclusion complexes of conjugated linoleic acid (CLA) with cyclodextrins, J. Agric. Food Chem. 50 (2002) 2977-2983.
4. Z. Cai, L. Wu, G. Zhong and S. Gao, Effects of inclusion of Citri reticulatae volatile oil by beta-cyclodextrin, Zhongguo Zhongyao Zazhi 20 (1995) 603-604;
5. ref. Chem. Abst. 124 (1996) 241719a.
6. M. Jug, M. Becirevic-Lacan, A. Kwokal and B. Cetina-Cizmek, Influence of cyclodextrin complexation on piroxicam gel formulations, Acta Pharm. 55 (2005) 223-236.
7. M. L. Manca, M. Zaru, G. Ennas, D. Valenti, C. Sinico, G. Loy and A. M. Fadda, Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies, AAPS Pharm. Sci. Tech. 6 (2005) E464-472.
8. K. Rajendrakumar, S. Madhusudan and T. Pralhad, Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat, Eur. J. Pharm. Biopharm. 60 (2005) 39-46.
9. W. L. Lu, Q. Zhang, L. Zheng, H. Wang, R. Y. Li, L. F. Zhang, W. B. Shen and X. D. Tu, Antipyretic, analgesic and anti-inflammatory activities of ketoprofen beta-cyclodextrin inclusion complexes in animals, Biol. Pharm. Bull. 27 (2004) 1515-1520.
10. S. K. Paulson, M. B. Vaughn, S. M. Jessen, Y. Lawal, C. J. Gresk, B. Yan, T. Maziasz, C. S. Cook and A. Karim, Pharmacokinetics of celecoxib after oral administration in dogs and human: Effect of food and site of absorption, J. Pharmacol. Exp. Ther. 297 (2001) 638-645.
11. USP 27/NF 22, The USP Convention, Rockville 2004, pp. 2303-2304.
12. G. Trapani, A. Latrofa, M. Franco, M. R. Pantaleo, E. Sanna, F. Masso, F. Tuveri and G. Liso, Complexation of zolpidem with 2-hydropropyl-β-methyl- β- and 2-hydroxypropyl-γ-cyclodextrins: Effect on aqueous solubility, dissolution rate and ataxic activity in rat, J. Pharm. Sci. 89 (2000) 1443-1451.
13. L. S. Koester, S. S. Guterres, M. Le Roch, V. L. Eifler-Lima, J. A. Zuanazzi and V. L. Bassani, Ofloxacin/beta-cyclodextrin complexation, Drug Dev. Ind. Pharm. 27 (2001) 533-540.
14. K. A. Connors, The stability of cyclodextrin complexes in solution, Chem. Rev. 97 (1997) 1325-1357.
15. H. Cabral Marques, J. Hadgraft and J. Kellaway, Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC, Int. J. Pharm. 63 (1990) 259-266.
16. P. Mura, M. T. Faucci and P. L. Parrini, Effect of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties, Drug Dev. Ind. Pharm. 27 (2001) 119-128.
17. P. Mura, E. Adragna, A. M. Rabasco, J. R. Moyano, J. I. Perez-Martinez, M. J. Arias and J. M. Gines, Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrin, Int. J. Pharm. 193 (1999) 85-95.
18. M. D. Veiga, P. J. Diaz and F. Ahsan, Interactions of griseofulvin with cyclodextrins in solid binary systems, J. Pharm. Sci. 87 (1998) 891-900.
19. M. Guyot, F. Fawaz, J. Bildet, F. Bonini and A. M. Lagueny, Physicochemical characterization and dissolution of norfloxacin/CD inclusion compounds and PEG solid dispersions, Int. J. Pharm. 123 (1995) 53-63.
20. C. M. Fernandes, M. T. Vieira and F. J. B. Veiga, Physicochemical characterization and in vitro dissolution behaviour of nicardipine-cyclodextrin inclusion compounds, Eur. J. Pharm. Sci. 15 (2002) 79-88.
21. P. Mura, G. P. Bettinetti, A. Manderiol, M. T. Faucci, G. Bramanti and M. Sorrenti, Interaction of ketoprofen and ibuprofen with β-cyclodextrin in solution and solid states, Int. J. Pharm. 166 (1998) 189-203.
22. C. A. Ventura, S. Trendi, G. Puglisi, E. Bousquet and L. Panza, Improvement of water solubility and dissolution rate of ursodeoxycholic acid and cheno deoxycholic acid by complexation with natural and modified beta-cyclodextrin, Int. J. Pharm. 149 (1997) 1-13.
23. P. Briard and J. C. Rossi, Ketoprofen, Acta Crystallogr. Cryst. Struct. Commun. 46 (1990) 1036-1038.
24. Y. Nakai, K. Yamamoto, K. Terada and H. J. Horibe, Interaction of tri-O-methyl-β-cyclodextrin with drugs, J. Incl. Phenom. Mol. Recognit. Chem. 2 (1984) 523-531.
25. M. Becirevic-Lacan, J. Filipovic-Grcic, N. Skalko and J. Jalsenjak, Dissolution characteristics of nifedipine complexes with β-cyclodextrins, Drug Dev. Ind. Pharm. 22 (1996) 1213-1236.
26. S. Ismail, Interaction of anticonvulsant drugs with alpha and beta-cyclodextrins. I. Methsumide, STP Pharm. Sci. 1 (1991) 321-325.
27. V. R. Sinha, R. Anitha, S. Ghosh and R. Kumria, Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state, J. Pharm. Sci. 94 (2005) 676-687.